Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,6,0.88 [0.81-0.96],0.00496415513063057,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_GALLBILPANC,Inverse variance weighted,5,1.12 [1.03-1.21],0.00587675640293004,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_LBBB,Inverse variance weighted,6,0.65 [0.48-0.89],0.00683812257781688,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,Inverse variance weighted,6,0.92 [0.87-0.98],0.0118606025921681,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,6,0.9 [0.82-0.98],0.0150535452390884,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,5,1.1 [1.02-1.19],0.0166633701281804,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,6,0.93 [0.88-0.99],0.0210386838192131,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,KRA_PSY_MOOD_EXMORE,Inverse variance weighted,5,1.12 [1.02-1.23],0.0211157200012545,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,6,1.16 [1.02-1.33],0.0273354597291018,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,5,0.78 [0.63-0.97],0.0286662768556958,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_VIRAL_IMPL,Inverse variance weighted,5,1.22 [1.02-1.46],0.0302439709796879,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,6,0.3 [0.1-0.9],0.0314000233546359,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_GENITOURINARY,Inverse variance weighted,5,1.05 [1-1.1],0.0317776516237147,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUEOTH,Inverse variance weighted,6,1.08 [1-1.16],0.0360652867693614,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,6,0.87 [0.76-0.99],0.038624507626305,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_COELIAC,Inverse variance weighted,6,1.33 [1.01-1.74],0.0418798648381006,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Inverse variance weighted,5,1.09 [1-1.19],0.0455083037321968,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,6,0.93 [0.86-1],0.0483223169300002,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,6,0.88 [0.77-1],0.0513237874206142,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,6,1.11 [1-1.24],0.055988275877844,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHANRECT,Inverse variance weighted,6,1.14 [1-1.31],0.0576067832272954,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_PRURITUS,Inverse variance weighted,6,0.79 [0.61-1.01],0.0591002085748947,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,6,0.92 [0.84-1],0.0607301192581609,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,6,0.94 [0.88-1],0.0640276743401369,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,6,0.91 [0.82-1.01],0.0688900175769128,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,6,0.88 [0.76-1.01],0.0725881537153395,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_SKIN_SUBCUTAN,Inverse variance weighted,5,1.05 [0.99-1.11],0.0834932382874963,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Inverse variance weighted,6,1.15 [0.98-1.35],0.0897230774678108,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSALGIANAS,Inverse variance weighted,6,1.1 [0.98-1.24],0.0959601756012769,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,6,1.11 [0.98-1.26],0.0971309934678427,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,6,1.26 [0.95-1.67],0.107226649392753,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUE,Inverse variance weighted,6,1.04 [0.99-1.09],0.119284004568641,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Inverse variance weighted,5,1.05 [0.99-1.12],0.126821225254469,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,6,1.97 [0.82-4.73],0.130063941188567,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_PULMOTHHD,Inverse variance weighted,5,1.24 [0.94-1.63],0.130757573147903,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,6,0.86 [0.7-1.05],0.131298394880344,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_CANDIDIASIS,Inverse variance weighted,6,1.18 [0.95-1.45],0.132615938331974,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,6,0.88 [0.74-1.04],0.133031671335419,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,6,1.26 [0.93-1.7],0.134489159694456,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,6,1.37 [0.91-2.07],0.135096581839097,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,6,1.18 [0.95-1.47],0.136824101327706,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,6,1.3 [0.92-1.84],0.138617235816456,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,Inverse variance weighted,6,1.65 [0.85-3.21],0.140730899614761,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,6,1.14 [0.96-1.35],0.143958123556023,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,6,0.88 [0.75-1.04],0.146499552950895,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,G6_EPLEPSY,Inverse variance weighted,6,1.1 [0.96-1.26],0.162519247495599,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,6,1.08 [0.96-1.22],0.184037367570383,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_VTE,Inverse variance weighted,6,0.94 [0.85-1.03],0.190093905282822,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SLE,Inverse variance weighted,5,2.07 [0.69-6.17],0.192696336481668,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,C3_NONHODGKIN_EXALLC,Inverse variance weighted,6,0.75 [0.48-1.17],0.205351750441336,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_SPLEENDISEASE,Inverse variance weighted,6,1.69 [0.75-3.82],0.206432917899597,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,6,0.95 [0.89-1.03],0.211337080353456,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHDISOES,Inverse variance weighted,6,1.17 [0.91-1.5],0.21187008548636,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_THROMBOCYTOPENIANAS,Inverse variance weighted,6,1.35 [0.84-2.15],0.212395116651744,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,6,1.05 [0.97-1.14],0.216379863982925,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Inverse variance weighted,6,1.16 [0.92-1.47],0.219114284703121,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OTHCONN,Inverse variance weighted,5,1.17 [0.91-1.52],0.222102627199648,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,6,0.89 [0.73-1.08],0.228298659531072,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,6,1.04 [0.97-1.12],0.229892438784155,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,6,1.11 [0.93-1.32],0.235387086164795,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_MI_STRICT,Inverse variance weighted,6,0.94 [0.85-1.04],0.242967844701773,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,6,0.9 [0.76-1.07],0.243581932493301,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FE_DEF,Inverse variance weighted,6,1.52 [0.74-3.11],0.256480022157849,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,6,0.92 [0.8-1.06],0.262026698026059,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_RESPDISOTH,Inverse variance weighted,5,1.06 [0.96-1.17],0.268424296640062,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOCHONDRO,Inverse variance weighted,6,0.94 [0.84-1.05],0.271281786091627,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,6,1.25 [0.83-1.88],0.280150384586619,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,Inverse variance weighted,6,0.92 [0.78-1.07],0.280845220611893,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,6,1.03 [0.98-1.09],0.283454247081373,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,6,1.05 [0.96-1.15],0.285024233057282,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHFUNC,Inverse variance weighted,6,1.1 [0.93-1.3],0.28825874635836,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Inverse variance weighted,5,1.05 [0.96-1.15],0.297580121354806,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,6,0.9 [0.75-1.09],0.299148129984304,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,Inverse variance weighted,6,0.78 [0.49-1.25],0.302964284591742,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,ALCOHOLMENTAL,Inverse variance weighted,5,1.12 [0.9-1.38],0.308105474427219,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,6,1.09 [0.92-1.28],0.310258243714185,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,6,0.8 [0.52-1.23],0.310799536756273,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H8_OTHEREAR,Inverse variance weighted,6,1.04 [0.96-1.13],0.313039828354068,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,NAFLD,Inverse variance weighted,6,0.87 [0.66-1.15],0.323940979806568,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_RHEUVALV,Inverse variance weighted,6,0.78 [0.47-1.29],0.336526141756316,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_MALABSORB,Inverse variance weighted,6,0.83 [0.57-1.22],0.343081337184369,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,6,1.03 [0.97-1.08],0.345504498344709,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,C3_BILIARY_GALLBLADDER_EXALLC,Inverse variance weighted,6,0.82 [0.54-1.24],0.354795065755274,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,6,0.92 [0.77-1.1],0.355345741982057,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,6,0.96 [0.89-1.04],0.358126037352476,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Inverse variance weighted,6,0.83 [0.55-1.25],0.369154717307889,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,6,1.03 [0.96-1.11],0.369406415832282,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,6,0.9 [0.72-1.13],0.370036144803944,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_EXPLICIT,Inverse variance weighted,5,1.05 [0.94-1.18],0.374075460041872,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,COLITNONINFNAS,Inverse variance weighted,5,0.96 [0.87-1.05],0.374912019871428,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Inverse variance weighted,5,1.05 [0.94-1.16],0.391157114666146,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_REFLUX,Inverse variance weighted,6,0.96 [0.88-1.05],0.399489276878882,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRLOW,Inverse variance weighted,6,0.83 [0.55-1.27],0.401181456893672,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_PNEUMOTHORAX,Inverse variance weighted,6,0.87 [0.64-1.2],0.410673426938852,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,6,1.19 [0.78-1.8],0.414602030798972,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,G6_HEMIPLE,Inverse variance weighted,6,0.87 [0.62-1.23],0.426351469045103,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,6,0.93 [0.79-1.11],0.428290201094973,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SJOGREN,Inverse variance weighted,6,1.11 [0.85-1.46],0.434989013169385,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERAPLASTICANAEMIA,Inverse variance weighted,6,0.74 [0.33-1.63],0.450361361176745,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,6,1.22 [0.73-2.05],0.451171932758255,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_BACT_IMPL,Inverse variance weighted,5,1.04 [0.94-1.16],0.452562216677333,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_BONEDENSOTH,Inverse variance weighted,6,1.37 [0.59-3.17],0.458356993515585,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_ARTOTH,Inverse variance weighted,6,0.88 [0.64-1.23],0.461919160998375,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,6,0.97 [0.91-1.04],0.461927086301666,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,6,1.08 [0.88-1.32],0.462933581546474,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_HEPFAIL,Inverse variance weighted,6,1.3 [0.63-2.68],0.472420360710593,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,5,1.02 [0.97-1.07],0.473022182889809,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,6,1.2 [0.73-1.98],0.474658941121425,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,6,0.81 [0.44-1.49],0.489699965251302,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,6,0.83 [0.48-1.42],0.493113778734906,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,6,1.03 [0.95-1.12],0.499151729802335,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_LUPUS,Inverse variance weighted,6,1.19 [0.71-2.02],0.506280411322833,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,6,0.97 [0.89-1.06],0.512257478562029,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,6,0.97 [0.88-1.07],0.519951655619319,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,6,1.05 [0.9-1.22],0.531058397794092,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_BRONCHIECTASIS,Inverse variance weighted,6,1.1 [0.82-1.46],0.531140579101985,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,6,0.96 [0.86-1.08],0.540660676812845,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_GIBLEEDING,Inverse variance weighted,5,0.96 [0.83-1.1],0.543251031478859,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_INTERSTITIUM,Inverse variance weighted,5,1.1 [0.8-1.52],0.544017654039073,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHY,Inverse variance weighted,6,1.02 [0.97-1.07],0.544535971361547,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,INFLUENZA,Inverse variance weighted,6,0.94 [0.78-1.14],0.552120139648894,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,COPD_LATER,Inverse variance weighted,6,0.96 [0.83-1.1],0.552384513419372,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHINFLIV,Inverse variance weighted,6,1.13 [0.76-1.67],0.553030375105787,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,C3_LUNG_NONSMALL_EXALLC,Inverse variance weighted,6,1.06 [0.87-1.29],0.567719847317638,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDOVER,Inverse variance weighted,5,1.08 [0.83-1.41],0.572251243725239,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,6,0.97 [0.87-1.08],0.57399587635145,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,6,1.08 [0.83-1.4],0.576319453650129,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_RBBB,Inverse variance weighted,6,1.13 [0.74-1.74],0.576742050745425,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHDISSTOMDUOD,Inverse variance weighted,6,0.91 [0.67-1.25],0.577393670235618,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,6,0.9 [0.63-1.29],0.578120040889321,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,6,1.26 [0.55-2.86],0.582587607650646,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,G6_EPIPAROX,Inverse variance weighted,6,1.01 [0.96-1.07],0.59060967136732,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_LOWBACKPAIN,Inverse variance weighted,6,1.02 [0.94-1.11],0.603229982186191,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_SARCOIDOSIS,Inverse variance weighted,6,0.95 [0.77-1.17],0.607989979789003,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,5,1.06 [0.85-1.32],0.610158561292825,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,6,1.06 [0.85-1.32],0.613859338391129,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_EXTERLUNG,Inverse variance weighted,6,1.08 [0.79-1.5],0.621105874656557,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,6,0.97 [0.87-1.09],0.621808980006763,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_CHD,Inverse variance weighted,6,0.98 [0.91-1.06],0.622178717883167,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_IRON_MET,Inverse variance weighted,6,0.83 [0.4-1.76],0.634182977946367,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,6,1.02 [0.95-1.09],0.635351816471,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_BACTINF_NOS,Inverse variance weighted,6,0.98 [0.88-1.08],0.662170867167187,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,6,0.93 [0.66-1.31],0.669901321682062,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,C3_BREAST_EXALLC,Inverse variance weighted,6,0.98 [0.87-1.1],0.684019345064558,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,6,0.98 [0.91-1.06],0.684818996948652,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_GIDISEASES,Inverse variance weighted,5,1.01 [0.97-1.05],0.687182212567198,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,6,0.98 [0.89-1.08],0.690065161884317,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,6,0.98 [0.87-1.1],0.691325421757546,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Inverse variance weighted,6,0.98 [0.88-1.09],0.696084504871215,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,6,1.09 [0.71-1.65],0.700201818402177,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_MUSCULOSKELETAL,Inverse variance weighted,5,1.01 [0.96-1.05],0.708262106680908,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,6,0.97 [0.85-1.12],0.719668285492887,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,6,1.04 [0.83-1.32],0.722508424942401,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHDISDIG,Inverse variance weighted,6,1.02 [0.9-1.17],0.724045817292471,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHINT,Inverse variance weighted,6,1.04 [0.82-1.33],0.727173640892429,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,6,0.94 [0.68-1.31],0.729647806471,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_FUNGAL_IMPL,Inverse variance weighted,5,0.95 [0.71-1.28],0.733310034573179,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,6,1.01 [0.93-1.1],0.742547039062885,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,6,1.01 [0.96-1.06],0.754199780950787,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,6,1.01 [0.93-1.1],0.756218654869473,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,6,0.94 [0.63-1.39],0.758639047277402,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,6,0.96 [0.72-1.27],0.760602880763642,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,F5_DELIRIUM,Inverse variance weighted,6,1.05 [0.76-1.44],0.765985602904347,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,6,0.96 [0.75-1.24],0.767194997621202,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,COPD_HOSPITAL_MAIN,Inverse variance weighted,5,0.98 [0.88-1.09],0.7683004112913,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,6,0.81 [0.19-3.44],0.775312778051321,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,G6_NEURO,Inverse variance weighted,5,0.99 [0.92-1.07],0.78268853305414,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,6,0.99 [0.9-1.09],0.790185316470049,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,F5_ALCOHOL_DEPENDENCE,Inverse variance weighted,6,1.02 [0.88-1.18],0.813940034395557,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,6,0.98 [0.86-1.12],0.816844289189667,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Inverse variance weighted,5,1.01 [0.94-1.07],0.817737985289475,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_AGRANULOCYTOSIS,Inverse variance weighted,6,1.04 [0.76-1.41],0.818821823558957,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_STR_SAH,Inverse variance weighted,5,1.02 [0.84-1.25],0.81926673023459,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_CROHN,Inverse variance weighted,5,0.96 [0.7-1.33],0.821583245187418,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,6,0.97 [0.75-1.26],0.824082060812119,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_STR_EXH,Inverse variance weighted,5,0.97 [0.76-1.25],0.839318778023814,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,6,1 [0.94-1.06],0.877769842139487,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_INFLUENZA,Inverse variance weighted,6,1.01 [0.87-1.17],0.879709226187823,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_INFECT_PARASIT,Inverse variance weighted,5,0.99 [0.93-1.06],0.881898275153173,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_PNEUMONISOLLIQ,Inverse variance weighted,6,1.03 [0.71-1.49],0.887715437771261,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_AORTANEUR,Inverse variance weighted,6,0.99 [0.8-1.22],0.890787949739902,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,6,0.98 [0.73-1.33],0.912113074656023,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,6,1 [0.96-1.05],0.912487375643078,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_VIRAL,Inverse variance weighted,6,1.01 [0.88-1.16],0.917134147927389,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,G6_CPETAL,Inverse variance weighted,6,1.01 [0.81-1.27],0.923098780342608,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,6,1 [0.9-1.1],0.924501943333933,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,6,1 [0.94-1.07],0.933893083540058,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_ABAORTANEUR,Inverse variance weighted,6,1.01 [0.77-1.33],0.941482314689068,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,6,0.99 [0.79-1.25],0.943111152596367,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,6,0.99 [0.73-1.34],0.950430592726721,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,6,1 [0.92-1.08],0.953312524853881,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,6,1 [0.91-1.1],0.954821733655999,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,6,1 [0.88-1.14],0.957392512079807,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,6,1.01 [0.82-1.24],0.9576719962127,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,6,1 [0.9-1.11],0.959383068985682,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,6,1.01 [0.77-1.31],0.964657394862686,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,6,1 [0.94-1.06],0.965031383513738,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Inverse variance weighted,6,1.01 [0.73-1.38],0.96932841308005,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,6,1.01 [0.65-1.57],0.970675658576441,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,Inverse variance weighted,6,1 [0.91-1.09],0.972582808226005,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,6,1 [0.91-1.09],0.984716046468133,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_UAP,Inverse variance weighted,6,1 [0.85-1.18],0.985933807935929,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_OTHOTH,Inverse variance weighted,6,1 [0.64-1.57],0.992264564145235,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_CD_NOUC,Inverse variance weighted,5,1 [0.73-1.36],0.999468945524849,cis
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_PSORIASIS,Inverse variance weighted,19,1.17 [1.07-1.28],0.000606952945787168,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHDISSTOMDUOD,Inverse variance weighted,19,1.31 [1.06-1.62],0.0131637508683737,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_PLEUREFFUSION,Inverse variance weighted,19,1.2 [1.04-1.38],0.0145136904804952,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,C3_BILIARY_GALLBLADDER_EXALLC,Inverse variance weighted,19,1.38 [1.06-1.81],0.0184453444887881,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DERMATITISECZEMA,Inverse variance weighted,19,1.05 [1.01-1.1],0.024106562645038,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,19,1.16 [1.01-1.34],0.0353752874999679,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_INFLUENZA,Inverse variance weighted,19,0.91 [0.83-1],0.0427263825164614,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_OTHPER,Inverse variance weighted,19,0.8 [0.64-0.99],0.0446229620274772,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,C3_LUNG_NONSMALL_EXALLC,Inverse variance weighted,19,1.18 [1-1.4],0.0509922923391763,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_EMPHYSEMA,Inverse variance weighted,19,1.21 [0.99-1.48],0.0593018483721752,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,19,1.04 [1-1.08],0.0593114317015374,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,COPD_EARLY,Inverse variance weighted,19,1.1 [1-1.22],0.0614484989820498,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_ALCOLIV,Inverse variance weighted,19,1.17 [0.99-1.38],0.0622420686530013,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,19,0.91 [0.83-1],0.0627342327191728,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_SEQULAE,Inverse variance weighted,19,0.92 [0.84-1.01],0.0679731301958002,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOKALAEMIA,Inverse variance weighted,19,1.15 [0.98-1.35],0.0975962745347551,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHINT,Inverse variance weighted,19,1.14 [0.98-1.33],0.0984894337826273,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,19,1.12 [0.98-1.28],0.0988449464689043,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_PLEURA,Inverse variance weighted,19,1.06 [0.99-1.14],0.108902344012312,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,19,0.94 [0.86-1.02],0.112313127586074,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_CONSTIPATION,Inverse variance weighted,19,0.96 [0.92-1.01],0.121415746930119,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_ABAORTANEUR,Inverse variance weighted,19,0.88 [0.75-1.03],0.121884028258653,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_MYCOSES,Inverse variance weighted,19,0.93 [0.84-1.02],0.127948011642347,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,19,1.04 [0.99-1.1],0.134021402754535,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Inverse variance weighted,19,0.74 [0.5-1.1],0.13953181619159,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Inverse variance weighted,19,1.04 [0.99-1.09],0.143831420657065,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_BACTINF_NOS,Inverse variance weighted,19,1.06 [0.98-1.15],0.145774528352746,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Inverse variance weighted,19,1.14 [0.95-1.35],0.152621238590359,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_OTHILLHEART,Inverse variance weighted,19,1.17 [0.94-1.46],0.155735718767281,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_CHRONEPHROPATH,Inverse variance weighted,19,1.2 [0.93-1.56],0.164559352972469,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_STR,Inverse variance weighted,19,0.96 [0.91-1.02],0.178393988882597,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_CHD,Inverse variance weighted,19,1.04 [0.98-1.11],0.180697083190618,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,IPF,Inverse variance weighted,19,1.14 [0.94-1.38],0.184744699436092,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_AORTANEUR,Inverse variance weighted,19,0.93 [0.83-1.04],0.186392247776464,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_VARICVEOES,Inverse variance weighted,19,1.2 [0.92-1.56],0.186767224716871,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_VTE,Inverse variance weighted,19,0.95 [0.87-1.03],0.18828174491092,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_IRON_MET,Inverse variance weighted,19,0.74 [0.46-1.19],0.213101648866022,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHGASTR,Inverse variance weighted,19,1.07 [0.96-1.18],0.215042070871416,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,19,1.06 [0.96-1.18],0.218575287976046,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_SECONDRIGHT,Inverse variance weighted,19,0.85 [0.65-1.1],0.220949401717352,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H8_OTHEREAR,Inverse variance weighted,19,1.03 [0.98-1.08],0.222201114819669,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_GLOMEINOTH,Inverse variance weighted,19,1.11 [0.94-1.32],0.228414534339791,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_ARTOTH,Inverse variance weighted,19,1.12 [0.93-1.34],0.234889478446435,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,F5_DELIRIUM,Inverse variance weighted,19,0.91 [0.78-1.06],0.237481152803671,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Inverse variance weighted,19,0.97 [0.92-1.02],0.239778235046832,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_UAP,Inverse variance weighted,19,1.05 [0.97-1.14],0.245488814347687,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_RBBB,Inverse variance weighted,19,0.85 [0.64-1.12],0.250913403932984,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,KRA_PSY_SUBSTANCE_EXMORE,Inverse variance weighted,19,0.96 [0.9-1.03],0.262687052963111,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_CHOLELITH,Inverse variance weighted,19,0.97 [0.92-1.02],0.265742291870316,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Inverse variance weighted,19,1.13 [0.9-1.41],0.280646930560831,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_PAROXTAC,Inverse variance weighted,19,1.06 [0.95-1.18],0.28231806220722,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_HYPTENSPUL,Inverse variance weighted,19,0.74 [0.42-1.29],0.28410757746984,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,INFLUENZA,Inverse variance weighted,19,0.94 [0.83-1.06],0.293870929278862,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERAPLASTICANAEMIA,Inverse variance weighted,19,1.33 [0.78-2.26],0.295969616450068,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,COPD_LATER,Inverse variance weighted,19,1.07 [0.94-1.21],0.301281219944175,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_CELLULITIS,Inverse variance weighted,19,0.95 [0.85-1.05],0.301953360885542,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,C3_NONHODGKIN_EXALLC,Inverse variance weighted,19,0.86 [0.64-1.15],0.304478713318384,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_LOWERINF,Inverse variance weighted,19,1.03 [0.97-1.1],0.306699063965701,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,F5_ALCOHOL_DEPENDENCE,Inverse variance weighted,19,1.05 [0.95-1.17],0.314868552272401,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_PRURITUS,Inverse variance weighted,19,1.08 [0.93-1.27],0.315574596987289,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_AGRANULOCYTOSIS,Inverse variance weighted,19,1.08 [0.93-1.26],0.318491341952624,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_HEPFAIL,Inverse variance weighted,19,1.17 [0.86-1.6],0.324109782369893,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,19,1.11 [0.9-1.38],0.329166312374619,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,19,1.04 [0.96-1.14],0.330422881834834,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,19,1.02 [0.98-1.06],0.335188051241752,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_ULCERLOWLIMB,Inverse variance weighted,19,1.07 [0.93-1.23],0.339937256033911,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,19,1.04 [0.96-1.14],0.350662290976777,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,G6_EPLEPSY,Inverse variance weighted,19,0.96 [0.88-1.05],0.352477743843455,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_CANDIDIASIS,Inverse variance weighted,19,0.94 [0.82-1.08],0.359946887876048,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUE,Inverse variance weighted,19,1.02 [0.98-1.06],0.371623280629995,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,19,0.98 [0.92-1.03],0.38094174806338,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,19,0.97 [0.91-1.04],0.383954820539038,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHFUNC,Inverse variance weighted,19,1.03 [0.96-1.11],0.40530015515009,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Inverse variance weighted,19,0.96 [0.87-1.06],0.406854304382612,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERCHOL,Inverse variance weighted,19,1.03 [0.96-1.1],0.408701070299119,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_ARTHROPATHIES,Inverse variance weighted,19,1.02 [0.98-1.06],0.41279468676531,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Inverse variance weighted,19,1.03 [0.96-1.1],0.419477935649242,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Inverse variance weighted,19,1.04 [0.95-1.13],0.42304624957842,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_VIRAL,Inverse variance weighted,19,0.96 [0.86-1.07],0.423718984867922,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_IHD,Inverse variance weighted,19,1.02 [0.97-1.07],0.426734937301859,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,CHIRHEP_NAS,Inverse variance weighted,19,1.11 [0.86-1.43],0.428222522310539,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHDIG,Inverse variance weighted,19,1.03 [0.95-1.12],0.434238274212392,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Inverse variance weighted,19,0.93 [0.76-1.13],0.437823822886616,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,F5_DEPRESSIO,Inverse variance weighted,19,1.02 [0.97-1.08],0.442654423329097,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHANRECT,Inverse variance weighted,19,1.03 [0.95-1.13],0.448646180321457,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSALGIANAS,Inverse variance weighted,19,0.97 [0.9-1.05],0.449468111040911,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,19,0.93 [0.76-1.13],0.47098197078053,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_MI_STRICT,Inverse variance weighted,19,1.03 [0.95-1.12],0.472369675685404,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_ANGINA,Inverse variance weighted,19,1.02 [0.96-1.09],0.472656104768295,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter II Neoplasms,C3_BREAST_EXALLC,Inverse variance weighted,19,0.97 [0.9-1.05],0.473100934894293,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Inverse variance weighted,19,1.05 [0.93-1.18],0.474083672104973,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,KRA_PSY_ANYMENTAL,Inverse variance weighted,19,0.98 [0.94-1.03],0.486332906386677,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,F5_DEPRESSION_DYSTHYMIA,Inverse variance weighted,19,0.98 [0.93-1.03],0.488733057640507,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_EXTERLUNG,Inverse variance weighted,19,1.05 [0.92-1.2],0.497284294762638,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_LIPOPROT,Inverse variance weighted,19,0.98 [0.93-1.03],0.49916339933251,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_BONEDENSOTH,Inverse variance weighted,19,1.12 [0.81-1.56],0.499289346025172,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIAINCHRONICDISEASE,Inverse variance weighted,19,1.12 [0.79-1.6],0.516296732901164,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHDISDIG,Inverse variance weighted,19,1.03 [0.93-1.15],0.51904121835181,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_HYPTENSESS,Inverse variance weighted,19,1.01 [0.97-1.05],0.539248475512024,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHDISOES,Inverse variance weighted,19,1.06 [0.89-1.26],0.54263421306233,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_URINOTH,Inverse variance weighted,19,0.99 [0.94-1.03],0.544263985610064,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Inverse variance weighted,19,0.99 [0.95-1.03],0.54503060059206,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,19,1.02 [0.95-1.1],0.550776646077556,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_REFLUX,Inverse variance weighted,19,0.98 [0.92-1.05],0.552674844746068,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_SARCOIDOSIS,Inverse variance weighted,19,0.96 [0.83-1.1],0.55387002105247,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_LOWBACKPAIN,Inverse variance weighted,19,1.02 [0.95-1.09],0.553921702150067,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SOFTTISSUEOTH,Inverse variance weighted,19,1.02 [0.96-1.08],0.563295971733375,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,Inverse variance weighted,19,0.91 [0.65-1.26],0.568801081604119,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MG_MET,Inverse variance weighted,19,1.22 [0.61-2.42],0.571681906405845,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_COELIAC,Inverse variance weighted,19,1.04 [0.89-1.22],0.585302868564831,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,19,1.02 [0.94-1.12],0.592386865918345,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_THYROID,Inverse variance weighted,19,1.01 [0.96-1.07],0.593358228694146,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACT_INOTHER,Inverse variance weighted,19,1.16 [0.68-1.98],0.597853297584118,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,SMOKING_DEPEND,Inverse variance weighted,19,1.05 [0.87-1.26],0.601657351118538,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VIT_D_DEF,Inverse variance weighted,19,0.88 [0.54-1.43],0.610331955476964,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_LUPUS,Inverse variance weighted,19,1.09 [0.78-1.53],0.611059640139667,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,G6_EPIPAROX,Inverse variance weighted,19,0.99 [0.94-1.04],0.612523211388586,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_CORATHER,Inverse variance weighted,19,1.02 [0.96-1.08],0.612588567857339,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERKALAEMIA,Inverse variance weighted,19,0.94 [0.73-1.2],0.613618813109072,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,19,0.98 [0.93-1.05],0.629873159754964,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,G6_HEMIPLE,Inverse variance weighted,19,1.06 [0.85-1.31],0.631572594788195,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_VOLUME,Inverse variance weighted,19,0.96 [0.81-1.14],0.644251965775213,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_HYPTENS,Inverse variance weighted,19,1.01 [0.97-1.05],0.659496812414265,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,FALLS,Inverse variance weighted,19,1.01 [0.97-1.05],0.679285242284291,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOCHONDRO,Inverse variance weighted,19,0.98 [0.9-1.07],0.680082675504185,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_SPLEENDISEASE,Inverse variance weighted,19,0.92 [0.6-1.41],0.688903235564395,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_PNEUMONISOLLIQ,Inverse variance weighted,19,1.04 [0.87-1.24],0.692498680242591,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,19,1.01 [0.96-1.06],0.6975203872544,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_BRONCHIECTASIS,Inverse variance weighted,19,1.05 [0.82-1.35],0.701111764630054,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,19,0.99 [0.95-1.04],0.704249123194108,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XII Diseases of the skin and subcutaneous tissue,L12_OTHERSKINSUBCUTIS,Inverse variance weighted,19,1.01 [0.95-1.07],0.717819376006177,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,19,0.99 [0.91-1.07],0.731316855229836,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHY,Inverse variance weighted,19,0.99 [0.96-1.03],0.734603684346977,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_SJOGREN,Inverse variance weighted,19,0.97 [0.81-1.16],0.747930463470179,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHINFLIV,Inverse variance weighted,19,1.03 [0.84-1.26],0.751457088883336,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_THROMBOCYTOPENIANAS,Inverse variance weighted,19,1.03 [0.85-1.26],0.763957975564126,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_RHEUVALV,Inverse variance weighted,19,1.07 [0.69-1.66],0.769433873255708,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,Inverse variance weighted,19,0.97 [0.8-1.18],0.779093375242961,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_DORSOPATHYOTH,Inverse variance weighted,19,0.99 [0.95-1.04],0.788458187077656,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_RENFAILNAS,Inverse variance weighted,19,0.98 [0.82-1.16],0.790343860586332,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_STREPTSTAPHYCOCC_INOTHER,Inverse variance weighted,19,0.89 [0.39-2.06],0.790352475428623,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,NAFLD,Inverse variance weighted,19,0.97 [0.78-1.21],0.797539841243967,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_HYPOTE,Inverse variance weighted,19,0.98 [0.86-1.12],0.815532774519616,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_AF,Inverse variance weighted,19,0.99 [0.91-1.08],0.857031054600816,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_BACT_BIR_OTHER_INF_AGENTS,Inverse variance weighted,19,0.99 [0.83-1.17],0.862122163615694,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Inverse variance weighted,19,1.01 [0.92-1.11],0.863020677548361,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_METABOLIA,Inverse variance weighted,19,1 [0.96-1.04],0.863546653124446,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_OSTEOPOROSIS,Inverse variance weighted,19,1.01 [0.91-1.12],0.868953880952134,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FE_DEF,Inverse variance weighted,19,0.96 [0.58-1.59],0.870599699271041,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,19,0.98 [0.81-1.2],0.870861292873045,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_PURPURA_AND3_OTHER_HAEMORRHAGIC,Inverse variance weighted,19,0.99 [0.86-1.13],0.871689406057725,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,19,1.01 [0.91-1.11],0.875202929836057,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_OTHOTH,Inverse variance weighted,19,0.98 [0.75-1.28],0.877985757239099,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_ACUTERENFAIL,Inverse variance weighted,19,1.01 [0.9-1.13],0.903662344825909,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter VI Diseases of the nervous system,G6_CPETAL,Inverse variance weighted,19,1.01 [0.87-1.17],0.924395012475576,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_HYPTENSRD,Inverse variance weighted,19,1.01 [0.75-1.36],0.927518927848841,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,19,1 [0.93-1.07],0.927616246597176,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_PNEUMOTHORAX,Inverse variance weighted,19,0.99 [0.82-1.2],0.933269246755779,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter V Mental and behavioural disorders,AUD,Inverse variance weighted,19,1 [0.92-1.08],0.936062921399419,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,19,1.01 [0.77-1.32],0.950148807761828,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_LBBB,Inverse variance weighted,19,1.01 [0.83-1.22],0.951801544395304,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter I Certain infectious and parasitic diseases,AB1_INTESTINAL_INFECTIONS,Inverse variance weighted,19,1 [0.95-1.05],0.962826954872411,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,19,1 [0.94-1.06],0.970323909022242,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRLOW,Inverse variance weighted,19,0.99 [0.72-1.38],0.974766047311186,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_MALABSORB,Inverse variance weighted,19,1 [0.77-1.3],0.978903240484939,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Inverse variance weighted,19,1 [0.85-1.19],0.987899668561746,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_FIBROCHIRLIV,Inverse variance weighted,19,1 [0.79-1.27],0.991730693632144,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter XI Diseases of the digestive system,K11_DISLIVOTH,Inverse variance weighted,19,1 [0.87-1.15],0.993327391531291,trans
TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Chapter X Diseases of the respiratory system,ILD,Inverse variance weighted,19,1 [0.87-1.16],0.995006980291269,trans
